On-Demand Intimacy Enhancement
Sexual Health
Enhances sexual desire and arousal by working through the nervous system, not vascular mechanics.
$229 / month
Starting at $175/mo with 3-month supply + WELCOME10
About
PT-141 — generically, bremelanotide — is a melanocortin-receptor agonist. Instead of working on blood flow the way Viagra and Cialis do, it acts in the brain: it activates MC4R receptors in the hypothalamus, the part of the nervous system that drives arousal and desire. That is why it works for both men and women, and why it targets wanting, not just the physical mechanics.
The active ingredient is FDA-approved (under the brand name Vyleesi) for hypoactive sexual desire disorder in premenopausal women, with clinical trials showing improved desire and satisfaction in both genders. It is dosed on demand — taken before anticipated activity, not daily — and it does not touch testosterone, estrogen, or any other hormone level.
PeRx ships PT-141 fully reconstituted from an FDA-registered 503A pharmacy. No mixing — insulin syringes and a step-by-step guide arrive in the box. It is a subcutaneous injection taken roughly 45 minutes before activity, at a provider-determined dose.
Enhances sexual desire by activating melanocortin receptors in the brain, the neurological source of libido.
On-demand dosing. Use it when you want to. No daily pills, no buildup, no hormone disruption.
Works for both men and women, targeting desire itself rather than just the physical mechanics.
Non-hormonal mechanism of action. PT-141 leaves testosterone, estrogen, and all other hormone levels untouched.
Bremelanotide is FDA-approved, with clinical trials confirming improved satisfaction scores in both men and women.
Why people explore PT-141
PT-141 binds MC4R receptors in the hypothalamus — the brain's arousal and desire center. It is a fundamentally different lever than blood-flow drugs, which is why it works on the part most people actually want help with: wanting.
Because the mechanism is neurological rather than vascular, PT-141 enhances desire and arousal in men and women alike — and the active ingredient is FDA-approved for low desire in women specifically.
No daily pill, no buildup, no tolerance, no hormone disruption. Take it when you want to. Testosterone, estrogen, and everything else stay exactly where they were.
Effects typically begin within 30–60 minutes and last several hours.
What it helps with
Ideal for
Those experiencing low sexual desire · Individuals seeking on-demand enhancement · Those preferring non-hormonal options · Adults looking to improve intimacy
The science
PT-141 activates melanocortin receptors in the brain, particularly MC4R, which play a crucial role in sexual arousal and desire. It works centrally through the nervous system rather than affecting vascular function directly.
PT-141 is taken on demand — a single subcutaneous injection roughly 45 minutes before anticipated activity, at a provider-determined dose.
PT-141 activates melanocortin receptors in the brain, particularly MC4R, which play a central role in sexual arousal and desire. It works through the nervous system rather than affecting vascular function — a different pathway from PDE5 inhibitors like Viagra.
Most people feel a shift in arousal within 30–60 minutes, lasting several hours; the first few uses are about finding your personal response window. Many report that simply having an effective option reduces performance anxiety on its own, and there is no tolerance buildup with on-demand use.
What the research shows
2019
Year bremelanotide (Vyleesi) was FDA-approved
30–60 min
Typical onset after a dose
Non-hormonal
No effect on testosterone, estrogen, or other hormones
MC4R
The hypothalamic receptor it activates
Our medication is delivered from a state-licensed pharmacy in our network, right to your door when you need it.
Our pharmacies perform third-party testing through FDA and DEA registered labs to run quality control checks for every compounded lot. They test four key characteristics associated with quality and safety.
Performed on every batch to confirm the active ingredient is present at the labeled concentration. Your vial contains exactly what it should.
Tests for the presence of bacteria, fungi, and other microorganisms. Every batch is tested and must meet the requirements of USP 797.1.
Screens for bacterial endotoxins that can cause fever or adverse reactions. Every batch is tested and must not exceed the threshold limits defined in USP 85.
Assesses the acid/base balance to ensure minimal irritation upon injection and confirm the solution is within the correct range for subcutaneous administration.
What to expect
Dose day
What you may notice: Most people feel increased warmth and a subtle shift in arousal within 30 to 60 minutes. Some experience mild flushing or nausea that passes quickly.
What’s happening: PT-141 is activating melanocortin receptors in your hypothalamus, triggering the neurological cascade that drives desire.
First few uses
What you may notice: You start to understand your personal response window and optimal timing. Effects typically last several hours.
What’s happening: Your body is calibrating to the peptide. Most people settle into a predictable response pattern within the first few uses.
Week 2–4
What you may notice: Greater confidence in intimate situations. Many report that knowing they have an effective option reduces performance anxiety on its own.
What’s happening: The psychological benefit compounds with the physiological effect — reduced anxiety often amplifies the response.
Month 2+
What you may notice: Consistent on-demand results. Some patients find they need it less frequently as confidence and intimacy patterns improve.
What’s happening: PT-141 continues to work on demand without tolerance buildup. Your provider may adjust dosing based on your experience.
Comparison
PT-141 works on desire; Viagra works on blood flow — here's how they differ.
| PT-141 | Viagra / PDE5 inhibitors | |
|---|---|---|
| Best for | Low desire and arousal — in both men and women | Erectile dysfunction — in men |
| How it works | Brain-based — activates desire pathways in the hypothalamus | Vascular — increases blood flow to the penis |
| Works for women? | Yes — FDA-approved for women with HSDD | No — designed for men only |
| Addresses desire? | Yes — enhances genuine arousal and wanting | No — addresses the physical mechanics only |
| Dosing | On-demand subcutaneous injection | On-demand oral pill |
What’s included
From the moment you finish your assessment to your first dose, every step is handled by licensed providers and U.S. pharmacies.
New to self-injection? See the step-by-step guideFAQ
Patient reviews
This is not medical advice. Every patient's experience differs and not everyone qualifies for peptide therapy. All reviews are from verified PeRx patients and are published as submitted. Peptide therapy requires a valid prescription from a licensed provider.
Your safety, first
All prescriptions are issued by a licensed US provider after reviewing your intake.
Side effects, contraindications, and what to discuss with your provider before starting.
Read safety informationSupporting research
A selection of peer-reviewed work on PT-141. Browse the full literature on PubMed and Google Scholar for ongoing research.
RECONNECT Phase 3 trial (women with HSDD)
Kingsberg SA et al. Obstet Gynecol. 2019;134(5):899–908.Erectile response in men, including sildenafil non-responders
Diamond LE et al. J Sex Med. 2006;3(4):628–638.Melanocortin-receptor mechanism review
Pfaus JG et al. Pharmacol Ther. 2016;161:11–23.The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The FDA does not review or approve compounded medications for safety or effectiveness. Off-label use must be prescribed and supervised by a licensed provider.
You may also be interested in
Last updated April 2026
Medical disclaimer
The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Peptide therapy requires a valid prescription from a licensed healthcare provider. Individual results may vary. No specific outcomes are guaranteed.
The peptides on this site are not FDA-approved. They are compounded by licensed pharmacies under provider supervision. Certain peptides are prohibited by WADA and major sports organizations. Statements on this page have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Take our 2-minute assessment. A licensed US provider reviews and, if appropriate, prescribes a protocol shipped to your door.
$229 / month
Starting at $175/mo with 3-month supply + WELCOME10
